Literature DB >> 897339

3H-delta9-tetrahydrocannabinol distribution in pregnant dogs and their fetuses.

B R Martin, W L Dewey, L S Harris, J S Beckner.   

Abstract

Pregnant dogs were administered intravenously 0.5 mg/kg of 3H-delta9-tetrahydrocannabinol and sacrificed at 30 minutes, the time of peak behavioral effects. The distribution of radioactivity in mothers and fetuses was quantified in many peripheral tissues and in major brain areas by sample combustion and liquid scintillation spectrometry. Brains were subfractionated by differential centrifugation in order to compare the subcellular localization of radioactivity in maternal and fetal brains. Although the level of radioactivity in maternal brain was three times higher than that in fetal brain, the distribution of radioactivity in the major brain areas was similar in mothers and fetuses. However, the subcellular distribution of radioactivity in whole brain homogenate of fetal dogs was markedly different from that in whole brain homogenates from mothers and appeared to be related directly to differing phospholipid content.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 897339

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN: 0034-5164


  9 in total

1.  Perinatal exposure to Δ9-tetrahydrocannabinol triggers profound defects in T cell differentiation and function in fetal and postnatal stages of life, including decreased responsiveness to HIV antigens.

Authors:  Catherine Lombard; Venkatesh L Hegde; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  J Pharmacol Exp Ther       Date:  2011-08-10       Impact factor: 4.030

Review 2.  Human cannabinoid pharmacokinetics.

Authors:  Marilyn A Huestis
Journal:  Chem Biodivers       Date:  2007-08       Impact factor: 2.408

Review 3.  Cannabis use during pregnancy: Pharmacokinetics and effects on child development.

Authors:  Kimberly S Grant; Rebekah Petroff; Nina Isoherranen; Nephi Stella; Thomas M Burbacher
Journal:  Pharmacol Ther       Date:  2017-08-25       Impact factor: 12.310

Review 4.  Pharmacokinetics and pharmacodynamics of cannabinoids.

Authors:  Franjo Grotenhermen
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

5.  Distribution of indoleamines and [3H]paroxetine binding in rat brain regions following acute or perinatal delta 9-tetrahydrocannabinol treatments.

Authors:  F Molina-Holgado; E Molina-Holgado; M L Leret; M I González; T A Reader
Journal:  Neurochem Res       Date:  1993-11       Impact factor: 3.996

Review 6.  Pediatric Concerns Due to Expanded Cannabis Use: Unintended Consequences of Legalization.

Authors:  George Sam Wang
Journal:  J Med Toxicol       Date:  2016-05-02

7.  Histamine release in dogs by Emulphor EL620.

Authors:  J W Constantine; W S Lebel
Journal:  Experientia       Date:  1979-03-15

Review 8.  Marijuana Use in Pregnancy: A Review.

Authors:  Rebecca Thompson; Katherine DeJong; Jamie Lo
Journal:  Obstet Gynecol Surv       Date:  2019-07       Impact factor: 2.347

Review 9.  The grass isn't always greener: The effects of cannabis on embryological development.

Authors:  Joseph Friedrich; Dara Khatib; Keon Parsa; Ariana Santopietro; G Ian Gallicano
Journal:  BMC Pharmacol Toxicol       Date:  2016-09-29       Impact factor: 2.483

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.